These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 1378822

  • 1. Replacement of Tyr-SO3H by a p-carboxymethyl-phenylalanine in a CCK8-derivative preserves its high affinity for CCK-B receptor.
    McCort-Tranchepain I, Ficheux D, Durieux C, Roques BP.
    Int J Pept Protein Res; 1992 Jan; 39(1):48-57. PubMed ID: 1378822
    [Abstract] [Full Text] [Related]

  • 2. Full agonists of CCK8 containing a nonhydrolyzable sulfated tyrosine residue.
    Marseigne I, Roy P, Dor A, Durieux C, Pélaprat D, Reibaud M, Blanchard JC, Roques BP.
    J Med Chem; 1989 Feb; 32(2):445-9. PubMed ID: 2464062
    [Abstract] [Full Text] [Related]

  • 3. Synthesis and binding affinities of cyclic and related linear analogues of CCK8 selective for central receptors.
    Charpentier B, Dor A, Roy P, England P, Pham H, Durieux C, Roques BP.
    J Med Chem; 1989 Jun; 32(6):1184-90. PubMed ID: 2724293
    [Abstract] [Full Text] [Related]

  • 4. Synthesis and biological evaluation of cholecystokinin analogs in which the Asp-Phe-NH2 moiety has been replaced by a 3-amino-7-phenylheptanoic acid or a 3-amino-6-(phenyloxy)hexanoic acid.
    Amblard M, Rodriguez M, Lignon MF, Galas MC, Bernad N, Artis-Noël AM, Hauad L, Laur J, Califano JC, Aumelas A.
    J Med Chem; 1993 Oct 01; 36(20):3021-8. PubMed ID: 7692048
    [Abstract] [Full Text] [Related]

  • 5. Boc-Trp-Orn(Z)-Asp-NH2 and derivatives: a new family of CCK antagonists.
    Gonzalez-Muniz R, Bergeron F, Marseigne I, Durieux C, Roques BP.
    J Med Chem; 1990 Dec 01; 33(12):3199-204. PubMed ID: 1701834
    [Abstract] [Full Text] [Related]

  • 6. Investigation of peripheral cholecystokinin receptor heterogeneity by cyclic and related linear analogues of CCK26-33: synthesis and biological properties.
    Charpentier B, Durieux C, Menant I, Roques BP.
    J Med Chem; 1987 Jun 01; 30(6):962-8. PubMed ID: 2438407
    [Abstract] [Full Text] [Related]

  • 7. Correlation between phospholipid breakdown, intracellular calcium mobilization and enzyme secretion in rat pancreatic acini treated with Boc-[Nle28, Nle31]-CCK-7 and JMV180, two cholecystokinin analogues.
    Lignon MF, Galas MC, Rodriguez M, Martinez J.
    Cell Signal; 1990 Jun 01; 2(4):339-46. PubMed ID: 1701321
    [Abstract] [Full Text] [Related]

  • 8. Carboxylic acids and tetrazoles as isosteric replacements for sulfate in cholecystokinin analogues.
    Tilley JW, Danho W, Lovey K, Wagner R, Swistok J, Makofske R, Michalewsky J, Triscari J, Nelson D, Weatherford S.
    J Med Chem; 1991 Mar 01; 34(3):1125-36. PubMed ID: 2002454
    [Abstract] [Full Text] [Related]

  • 9. Synthesis and biological activity of CCK26-33-related analogues modified in position 31.
    Marseigne I, Dor A, Bégué D, Reibaud M, Zundel JL, Blanchard JC, Pélaprat D, Roques BP.
    J Med Chem; 1988 May 01; 31(5):966-70. PubMed ID: 2452253
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Study of the states and populations of the rat pancreatic cholecystokinin receptor using the full peptide antagonist JMV 179.
    Silvente Poirot S, Hadjiivanova C, Escrieut C, Dufresne M, Martinez J, Vaysse N, Fourmy D.
    Eur J Biochem; 1993 Mar 01; 212(2):529-38. PubMed ID: 8444190
    [Abstract] [Full Text] [Related]

  • 16. Cyclic cholecystokinin analogues with high selectivity for central receptors.
    Charpentier B, Pelaprat D, Durieux C, Dor A, Reibaud M, Blanchard JC, Roques BP.
    Proc Natl Acad Sci U S A; 1988 Mar 01; 85(6):1968-72. PubMed ID: 3162318
    [Abstract] [Full Text] [Related]

  • 17. Development of potent and selective CCK-A receptor agonists from Boc-CCK-4: tetrapeptides containing Lys(N epsilon)-amide residues.
    Shiosaki K, Lin CW, Kopecka H, Craig RA, Bianchi BR, Miller TR, Witte DG, Stashko M, Nadzan AM.
    J Med Chem; 1992 May 29; 35(11):2007-14. PubMed ID: 1375964
    [Abstract] [Full Text] [Related]

  • 18. CCK-B agonist or antagonist activities of structurally hindered and peptidase-resistant Boc-CCK4 derivatives.
    Corringer PJ, Weng JH, Ducos B, Durieux C, Boudeau P, Bohme A, Roques BP.
    J Med Chem; 1993 Jan 08; 36(1):166-72. PubMed ID: 8421283
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.